Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Michael CatelaniPresident, COO, & CFO | Anixa BiosciencesANIX | Open-market buy | 09/30 | 09/30 | 5,500 sh | $2.84 | $15,620 | +12.4% |
Amit KumarCEO | Anixa BiosciencesANIX | Open-market buy | 09/24 | 09/28 | 7,000 sh | $2.78 | $19,460 | +1.1% |
Arnold M. BaskiesDirector | Anixa BiosciencesANIX | Open-market buy | 09/24 | 09/28 | 5,000 sh | $2.76 | $13,800 | +3.7% |
Lewis H. Titterton Jr.Director | Anixa BiosciencesANIX | Open-market buy | 09/23 | 09/25 | 49,036 sh | $2.69 | $131,906.84 | +4.9% |
Lewis H. Titterton Jr.Director | Anixa BiosciencesANIX | Open-market buy | 06/16 | 06/17 | 2,836 sh | $2.64 | $7,487.04 | +0.3% |
Amit KumarCEO | Anixa BiosciencesANIX | Open-market buy | 06/12 | 06/16 | 21,000 sh | $2.50 | $52,500 | +3.4% |
Arnold M. BaskiesDirector | Anixa BiosciencesANIX | Open-market buy | 01/28 | 01/29 | 10,000 sh | $3.04 | $30,400 | +8.0% |
Lewis H. Titterton Jr.Director | Anixa BiosciencesANIX | Open-market buy | 25/07/31 | 25/08/04 | 10,000 sh | $3.08 | $30,800 | +1.1% |
Amit KumarCEO | Anixa BiosciencesANIX | Open-market buy | 25/07/30 | 25/07/31 | 5,000 sh | $3.16 | $15,800 | +0.9% |
Arnold M. BaskiesDirector | Anixa BiosciencesANIX | Open-market buy | 25/07/18 | 25/07/21 | 5,000 sh | $3.39 | $16,950 | +4.2% |
Lewis H. Titterton Jr.Director | Anixa BiosciencesANIX | Open-market buy | 25/07/11 | 25/07/15 | 10,000 sh | $3.14 | $31,400 | +1.1% |
Amit KumarCEO | Anixa BiosciencesANIX | Open-market buy | 25/07/11 | 25/07/14 | 5,000 sh | $3.15 | $15,750 | +0.9% |
Amit KumarCEO | Anixa BiosciencesANIX | Open-market buy | 25/06/04 | 25/06/05 | 10,000 sh | $2.85 | $28,500 | +1.8% |
Arnold M. BaskiesDirector | Anixa BiosciencesANIX | Open-market buy | 25/01/28 | 25/01/29 | 5,000 sh | $2.82 | $14,100 | +4.3% |
Anixa BiosciencesANIX | Open-market buy | 25/01/23–25/01/24 | 25/01/27 | 3,000 sh2 trades | $2.94avg. | $8,820 | +0.3% | |
Lewis H. Titterton Jr.Director | Anixa BiosciencesANIX | Open-market buy | 25/01/22 | 25/01/23 | 2,000 sh | $3.01 | $6,020 | +0.2% |
Lewis H. Titterton Jr.Director | Anixa BiosciencesANIX | Open-market buy | 25/01/21 | 25/01/22 | 6,000 sh | $2.59 | $15,540 | +0.7% |
Lewis H. Titterton Jr.Director | Anixa BiosciencesANIX | Open-market buy | 25/01/17 | 25/01/17 | 10,000 sh | $2.57 | $25,700 | +1.1% |
Amit KumarCEO | Anixa BiosciencesANIX | Open-market buy | 25/01/15 | 25/01/15 | 43,000 sh | $2.23 | $95,890 | +8.3% |
Michael CatelaniPresident, COO, & CFO | Anixa BiosciencesANIX | Open-market buy | 25/01/15 | 25/01/15 | 9,289 sh | $2.15 | $19,971.35 | +26.4% |